Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCPK:MURGY) Q3 2025 Earnings Call November 11, 2025 5:00 AM EST Company Participants Christian Becker-Hussong - Head of Investor & Rating Agency Relations Christoph Jurecka - CFO & Member of Management Board Andrew Buchanan Conference Call Participants Shanti Kang - BofA Securities, Research Division Andrew Baker - Goldman Sachs Group, Inc., Research Division Michael Huttner - Joh. Berenberg, Gossler & Co. KG, Research Division Kamran Hossain - JPMorgan Chase & Co, Research Division Ivan Bokhmat - Barclays Bank PLC, Research Division Christopher Hartwell Vinit Malhotra - Mediobanca - Banca di credito finanziario S.p.A.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München aka Munich Re maintains strong earnings momentum, driven by low catastrophe losses and robust investment returns, supporting its reputation as a resilient income play. MURGY's net profit is expected to surpass guidance for 2025, with potential for a higher-than-expected dividend increase due to excess capital and conservative payout ratios. Despite solid fundamentals and a sustainable dividend, MURGY's valuation is near historical highs, limiting near-term upside and making its dividend yield only average among peers.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCPK:MURGY) Q2 2025 Earnings Conference Call August 8, 2025 5:00 AM ET Company Participants Christian Becker-Hussong - Head of Investor & Rating Agency Relations Christoph Jurecka - CFO & Member of Management Board Joachim Wenning - Chairman of Management Board Conference Call Participants Darius Satkauskas - Keefe, Bruyette, & Woods, Inc., Research Division Iain Pearce - BNP Paribas Exane, Research Division Ivan Bokhmat - Barclays Bank PLC, Research Division James Austin Shuck - Citigroup Inc., Research Division Jochen Schmitt - Metzler Equities, Research Division Kamran Mark Hossain - JPMorgan Chase & Co, Research Division Michael Igor Huttner - Joh. Berenberg, Gossler & Co. KG, Research Division Shanti Kang - BofA Securities, Research Division Vinit Malhotra - Mediobanca—Banca di credito finanziario S.p.A.
Mnchener RckversicherungsGesellschaft (MURGY) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Mnchener RckversicherungsGesellschaft (MURGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCPK:MURGY) Q1 2025 Results Conference Call May 13, 2025 5:30 PM ET Company Participants Christian Becker-Hussong - Head, Investor & Rating Agency Relations Christoph Jurecka - Chief Financial Officer Conference Call Participants Andrew Baker - Goldman Sachs Michael Huttner - Berenberg Kamran Hossain - JPMorgan Ivan Bokhmat - Barclays Shanti Kang - Bank of America Will Hardcastle - UBS Chris Hartwell - Autonomous Darius Satkauskas - KBW Vinit Malhotra - Mediobanca Iain Pearce - Exane BNP Paribas Faizan Lakhani - HSBC James Shuck - Citi Operator Ladies and gentlemen, welcome to the quarterly statement as of March 31, 2025, of Munich Re. I'm Moritz, the Chorus Call operator.
Investors with an interest in Insurance - Multi line stocks have likely encountered both M?nchener R?ckversicherungs-Gesellschaft (MURGY) and Goosehead Insurance (GSHD). But which of these two stocks presents investors with the better value opportunity right now?
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCPK:MURGY) Q4 2024 Earnings Call Transcript February 26, 2025 5:00 AM ET Company Participants Christian Becker-Hussong - Head, Investor & Rating Agency Relations Joachim Wenning - Chief Executive Officer Christoph Jurecka - Chief Financial Officer Conference Call Participants Andrew Baker - Goldman Sachs Kamran Hossain - JPMorgan James Shuck - Citi William Hardcastle - UBS Iain Pearce - Exane Ivan Bokhmat - Barclays Darius Satkauskas - KBW Shanti Kang - Bank of America Merrill Lynch Faizan Lakhani - HSBC Henry Heathfield - Morningstar Chris Hartwell - Autonomous Vinit Malhotra - Mediobanca Michael Huttner - Berenberg Bank Aliénor Fender - ODDO BHF Operator Ladies and gentlemen, welcome to the Analyst Investors Call on Annual Results and January Renewals Conference Call and Live Webcast. I'm Moritz, the Chorus Call operator.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCPK:MURGY) Q3 2024 Earnings Conference Call November 7, 2024 3:00 AM ET Company Participants Christian Becker-Hussong - Head, Investor & Rating Agency Relations Christoph Jurecka - Chief Financial Officer Conference Call Participants Andrew Baker - Goldman Sachs Michael Huttner - Berenberg Bank Kamran Hossain - JPMorgan Ivan Bokhmat - Barclays Vinit Malhotra - Mediobanca Ismael Dabo - Morgan Stanley James Shuck - Citi William Hardcastle - UBS Faizan Lakhani - HSBC Shanti Kang - Bank of America Christian Becker-Hussong Yes. Thank you, Moritz, and good morning, everyone.
Munich Re's sustainable dividend and strong capital position make it a solid long-term income play, despite recent hurricane-related earnings risks. H1 2024 performance was strong with a 55% YoY net income increase, but H2 2024 faces potential downward revisions due to high catastrophe losses. The company's Solvency II ratio of 287% indicates robust financial health, allowing it to maintain its dividend growth target despite short-term challenges.
Investors looking for stocks in the Insurance - Multi line sector might want to consider either M?nchener R?ckversicherungs-Gesellschaft (MURGY) or BB Seguridade Participacoes SA (BBSEY). But which of these two companies is the best option for those looking for undervalued stocks?
Does M?nchener R?ckversicherungs-Gesellschaft (MURGY) have what it takes to be a top stock pick for momentum investors? Let's find out.